UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Discover innovative ways to get more from credit card points. Maximize your rewards and enjoy greater benefits now.
27,256 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Ferrari's latest results underscore its asset-like status, delivering strong cash flow while preparing for an electri...
Institutional buyers stepped back into Bitcoin, lifting spot ETF inflows and signaling a shift back toward the market...
Major cryptocurrencies hold support as regulatory and macro headlines shape momentum. The crypto price prediction tod...
Nvidia’s CEO Jensen Huang faces a modest cash bonus despite a multitrillion-dollar market cap, highlighting how execu...
Oil prices retreat, lifting major indexes as traders react to easing energy costs and a cautious economic backdrop. T...
TAO jumps more than 10% in a single session as Bitcoin targets $72,000. The move sets the tone for a weekend of volat...
Solana climbs toward the $100 threshold as institutional ETF demand and rising open interest boost the token’s moment...
Hong Kong’s RedotPay is exploring a fundraising round of up to $150 million ahead of a potential U.S. IPO, according ...
The S&P 500 has slipped this year, yet three tech-focused ETFs powering AI names have kept a higher trajectory over t...
When markets wobble, income-focused investors flock to high-yield ETFs. This piece dives into why the JPMorgan Equity...
A hypothetical retiree with $4.6 million must choose how to gift $125,000 without triggering a heavy tax bill. Clark ...